What this is
- How it works
- How it works isn't classified yet
- Main trialPhase 1/2
- “The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of single doses of RN0361 in Adult healthy subjects and Adult Hypertriglyceridemic Subjects.”In the company’s words, NCT06471543 on ClinicalTrials.gov
Other drugs for Hypertriglyceridemia
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Active, not recruiting | 3 Jun 2026 | Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026